A new study will explore how psilocybin affects different networks and serotonin function in the brains of autistic adults.
Researchers explore the effect psychedelics have on the brain and how they are effective at treating depression.
People with depression who responded to psilocybin therapy showed an increase in brain connectivity for up to three weeks following treatment. The increased brain connectivity was correlated with self-reported improvements in depression symptoms.
Opioid use disorder is 30% less common in those who used psilocybin compared to those who have never been exposed to the psychedelic. Researchers say psilocybin may protect against opioid addiction by affecting the transmission of dopamine and serotonin.
The antidepressant effect of psilocybin-assisted therapy, in combination with psychotherapy, appears to provide up to a year of symptom relief for some patients with major depressive disorder.
Study demonstrates the safety and feasibility of psilocybin for the treatment of mental health disorders.
A growing body of evidence suggests psychedelics including psilocybin and LSD show promise in providing lasting relief from symptoms for those suffering some mental health disorders. Researchers found DOI, a similar drug to LSD, reduced negative behavioral responses following fear triggers in mouse models of anxiety.
Psilocybin, a natural psychoactive compound currently being considered for the treatment of depression, alters people's emotional states while listening to music. While listening to music, those who used psilocybin reported enhanced emotional processing. Researchers say combining music with psychedelic therapy may have positive benefits for those suffering from depression.
One dose of psilocybin, the psychoactive compound found in magic mushrooms, increases dendritic spine density within 24 hours. The neurobiological changes lasted for a month following psilocybin exposure. Additionally, mice subjected to stress showed behavioral improvements and increased neurotransmitter activity after psilocybin exposure.